High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases

Genomics

Volumn 81, Issue 5, 2003, Pages 510-518

  Herbon, Nicole ^a   Werner, Monika ^a   Braig, Christine ^a   Gohlke, Henning ^a   Dütsch, Gaby ^a   Illig, Thomas ^a   Altmüller, Janine ^a   Hampe, Jochen ^b   Lantermann, Annette ^b   Schreiber, Stefan ^b   Bonifacio, Ezio ^c   Ziegler, Annette ^c   Schwab, Sibylle ^d   Wildenauer, Dieter ^d   Van Den Boom, Dirk ^e   Braun, Andreas ^e   Knapp, Michael ^d   Reitmeir, Peter ^a   Wjst, Matthias ^a,f  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e SEQUENOM INC   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

6p21; Asthma; Crohn's disease; Diabetes; DNA pooling; Genotyping; HLA; Schizophrenia; SNP

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PROTEIN MICA; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHROMOSOME 6P; CONTROLLED STUDY; CROHN DISEASE; DNA DETERMINATION; DNA MICROARRAY; FEMALE; GENE FREQUENCY; GENE POOL; GENETIC SCREENING; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0037404767     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0888-7543(02)00035-6     Document Type: Article

References (40)

1. D.C. Rao, D.A. Province (Eds.), Genetic Dissection of Complex Traits: an overview Academic Press, London, 2002, 13-34.
2. Altmüller J., Palmer L.J., Fischer G., Scherb H., Wjst M. Genomewide scans of complex human diseases true linkage is hard to find . Am. J. Hum. Genet. 69:2001;936-950.
3. Johnson G.C., et al. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29:2001;233-237.
4. Patil N., et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science. 294:2001;1719-1723.
5. Buetow K.H., et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl. Acad. Sci. USA. 98:2001;581-584.
6. Arbour N.C., et al. Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling. Hum. Mol. Genet. 6:1997;689-694.
7. Complete sequence and gene map of a human major histocompatibility complex. Nature. 401:1999;921-923.
8. Milner C.M., Cambell R.D., Trowsdale J. Molecular genetics of the human major histocompatibility complex. Lechler R., Warrens A. HLA in Health and Disease. 2000;35-50 Academic Press, London.
9. Bontrop R.E. The evolution of the major histocompatibility complex insights from phylogeny . Lechler R., Warrens A. HLA in Health and Disease. 2000;163-169 Academic Press, London.
10. Reich D.E., et al. Linkage disequilibrium in the human genome. Nature. 411:2001;199-204.
11. Carrington M. Recombination within the human MHC. Immunol. Rev. 167:1999;245-256.
12. Zavattari P., et al. Major factors influencing linkage disequilibrium by analysis of different chromosome regions in distinct populations demography, chromosome recombination frequency and selection . Hum. Mol. Genet. 9:2000;2947-2957.
13. Hampe J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 357:2001;1925-1928.
14. Schwab S.G., et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings support for loci on chromosome 10p and 6 . Mol. Psychiatry. 5:2000;638-649.
15. Wjst M., et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics. 58:1999;1-8. doi:10.1006/geno.1999.5806.
16. Boretto J., et al. Anonymous markers located on chromosome 6 in the HLA-A class I region allelic distribution in genetic haemochromatosis . Hum. Genet. 89:1992;33-36.
17. Amor M., Parker K.L., Globerman H., New M.I., White P.C. Mutation in the CYP21B gene (lle172Asn) causes steroid 21-hydroxylase deficiency. Proc. Natl. Acad. Sci. USA. 85:1988;1600-1604.
18. Undlien D.E., Thorsby E. HLA associations in type 1 diabetes merging genetics and immunology . Trends Immunol. 22:2001;467-469.
19. Cox N.J., et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am. J. Hum. Genet. 69:2001;820-830.
20. Werner M., et al. Large-scale determination of SNP allele frequencies in DNA pools using MALDI-TOF mass spectrometry. Hum. Mutat. 20:2002;57-64.
21. Schlag E.W., Grotemeyer J., Levine R.D. Do large molecules ionize? Chem. Phys. Lett. 190:1992;521-527.
22. Bray M.S., Boerwinkle E., Doris P.A. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry practice, problems and promise . Hum. Mutat. 17:2001;296-304.
23. Gut I.G. Automation in genotyping of single nucleotide polymorphisms. Hum. Mutat. 17:2001;475-492.
24. Chakravarti A. Population genetics-making sense out of sequence. Nat. Genet. 21:1999;56-60.
25. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17:2001;502-510.
26. Asumalahti K., et al. Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum. Mol. Gen. 1:2002;589-597.
27. McGovern D.P., van Heel D.A., Ahmad T., Jewell D.P. NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut. 49:2001;752-754.
28. DeWan A.T., Parrado A.R., Matise T.C., Leal S.M. The map problem a comparison of genetic and sequence-based physical maps . Am. J. Hum. Genet. 70:2002;101-107.
29. Katsanis N., Worley K.C., Lupski J.R. An evaluation of the draft human genome sequence. Nat. Genet. 29:2001;88-91.
30. Seki S.S., et al. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese. Tissue Antigens. 58:2001;71-76.
31. Kawasaki A., Tsuchiya N., Hagiwara K., Takazoe M., Tokunaga K. Independent contribution of HLA-DRB1 and TNF- promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun. 1:2000;351-357.
32. Moffatt M.F., et al. Association between quantitative traits underlying asthma and the HLA-DRB1 locus in a family-based population sample. Eur. J. Hum. Genet. 9:2001;341-346.
33. Hampe J., et al. Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA. 99:2002;321-326.
34. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
35. Ogura Y., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606.
36. Ziegler A.G., Hummel M., Schenker M., Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes the 2-year analysis of the German BABYDIAB Study . Diabetes. 48:1999;460-468.
37. Little D.P., et al. Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. J. Mol. Med. 75:1997;745-750.
38. Little D.P., Braun A., Darnhofer-Demar B., Köster H. Identification of apolipoprotein E polymorphisms using temperature cycled primer oligo base extension and mass spectrometry. Eur. J. Clin. Chem. Clin. Biochem. 35:1997;545-548.
39. Devlin B., Roeder K. Genomic control for association studies. Biometrics. 55:1999;997-1004.
40. Benjamini Y., Hochberg Y. Controlling the false discovery rate a practical and powerful approach to multiple testing . J. R. Stat. Soc. B57:1995;289-300.